NYSE:HQL abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis $17.55 -0.02 (-0.09%) Closing price 03:58 PM EasternExtended Trading$17.55 +0.00 (+0.03%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About abrdn Life Sciences Investors Stock (NYSE:HQL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get HQL alerts:Sign Up Key Stats Today's Range$17.32▼$17.6950-Day Range$17.55▼$22.6452-Week Range$15.66▼$22.67Volume92,927 shsAverage Volume129,800 shsMarket Capitalization$533.54 millionP/E RatioN/ADividend Yield12.77%Price TargetN/AConsensus RatingN/A Company Overview abrdn Life Sciences Investors (NYSE: HQL) is a diversified, closed-end investment company focused on the life sciences sector. The fund seeks long-term capital appreciation by investing in companies involved in biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services and related industries. Its portfolio may include both publicly traded and privately held businesses across various stages of development, from emerging companies developing new therapies and technologies to more established healthcare enterprises. Through these investments, the fund provides exposure to areas such as drug discovery, medical research, therapeutic products and healthcare innovation. The fund was formerly known as Tekla Life Sciences Investors and is managed by abrdn, a global investment company. Its investments may span life sciences businesses in the United States and international markets, subject to the fund’s investment strategy and policies.AI Generated. May Contain Errors. Read More Receive HQL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HQL Stock News HeadlinesHQL: The Rally That Makes Growth Harder (Rating Downgrade)September 15, 2026 | seekingalpha.comabrdn Life Sciences Investors Q2 2026 CommentaryAugust 13, 2026 | seekingalpha.comThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.October 7 at 1:00 AM | Reagan Gold Group (Ad)abrdn Life Sciences Investors Q1 2026 CommentaryMay 20, 2026 | seekingalpha.comHQL: Attractive Outlook With Growth Of GLP-1 MarketMay 19, 2026 | seekingalpha.comabrdn Life Sciences Investors declares $0.56 dividendMay 12, 2026 | seekingalpha.comCertain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and AmountsMay 11, 2026 | prnewswire.comAbrdn Life Sciences Investors Fund Q4 2025 CommentaryFebruary 25, 2026 | seekingalpha.comSee More Headlines HQL Stock Analysis - Frequently Asked Questions How have HQL shares performed this year? abrdn Life Sciences Investors' stock was trading at $16.79 at the beginning of the year. Since then, HQL stock has increased by 4.5% and is now trading at $17.5450. How do I buy shares of abrdn Life Sciences Investors? Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of abrdn Life Sciences Investors own? Based on aggregate information from My MarketBeat watchlists, some other companies that abrdn Life Sciences Investors investors own include Rithm Capital (RITM), DoubleLine Income Solutions Fund (DSL), Verizon Communications (VZ), International Business Machines (IBM), Eaton Vance Tax-Managed Global Diversified Equity Income Fund (EXG) and Energy Transfer (ET). Company Calendar Record date for 9/30 Dividend8/24/2026Ex-Dividend for 9/30 Dividend8/24/2026Record date for 8/31 Dividend8/24/2026Ex-Dividend for 8/31 Dividend8/24/2026Dividend Payable8/31/2026Dividend Payable9/30/2026Today10/07/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (6d) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 6 days, HQL's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Capital Markets Sub-IndustryN/A Current SymbolNYSE:HQL CIK884121 Webwww.abrdnhql.com Phone(617) 772-8500Fax617-772-8577EmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares30,410,000Free Float27,349,000Market Cap$533.54 million OptionableNot Optionable Beta0.77 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NYSE:HQL) was last updated on 10/7/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
